Stockscreener 앱 받기
34.97
5.13%
-1.89
시간 외 거래:
35.00
0.03
+0.09%
전일 마감가:
$36.86
열려 있는:
$36.71
하루 거래량:
11.27M
Relative Volume:
0.45
시가총액:
$7.96B
수익:
$1.78B
순이익/손실:
$164.40M
주가수익비율:
50.68
EPS:
0.69
순현금흐름:
$236.51M
1주 성능:
-7.68%
1개월 성능:
-1.71%
6개월 성능:
-40.97%
1년 성능:
+12.37%
1일 변동 폭
$34.90
$37.61
1주일 범위
$34.90
$38.88
52주 변동 폭
$23.97
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
명칭
Hims Hers Health Inc
전화
415-851-0195
주소
2269 CHESTNUT ST, SAN FRANCISCO
HIMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
34.97 | 8.39B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
122.25 | 54.31B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.47 | 45.90B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.86B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.06 | 34.53B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
510.94 | 21.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-10-21 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | 다운그레이드 | Needham | Buy → Hold |
| 2025-06-04 | 재확인 | Needham | Buy |
| 2025-04-29 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-01-07 | 개시 | BTIG Research | Buy |
| 2024-12-17 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-08-22 | 개시 | Needham | Buy |
| 2024-08-09 | 다운그레이드 | Imperial Capital | Outperform → In-line |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-04-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-04-10 | 개시 | Canaccord Genuity | Buy |
| 2024-02-28 | 업그레이드 | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-07 | 개시 | Imperial Capital | In-line |
| 2023-07-28 | 개시 | TD Cowen | Outperform |
| 2023-04-11 | 개시 | Robert W. Baird | Neutral |
| 2023-02-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-08 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-07-15 | 개시 | SVB Leerink | Underperform |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-10 | 개시 | Deutsche Bank | Hold |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-11-11 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 개시 | BofA Securities | Neutral |
| 2021-05-20 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 개시 | Truist | Hold |
| 2021-03-09 | 개시 | Credit Suisse | Neutral |
| 2021-03-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 개시 | Citigroup | Neutral |
| 2021-02-12 | 개시 | Piper Sandler | Neutral |
| 2021-02-08 | 개시 | Tigress Financial | Buy |
모두보기
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Digital health giant Hims & Hers invests $200 million to expand Ohio life sciences hub - Ohio Tech News
Telehealth company Hims & Hers investing $200 million in New Albany - The Columbus Dispatch
Hims & Hers to invest $200M in New Albany expansion, create 400 jobs - The Business Journals
Hamilton Lane Advisors LLC Takes Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Leadership Executes Planned Stock Transactions - AD HOC NEWS
Hims & Hers Health (HIMS): Taking Stock of Valuation After a Sharp 90‑Day Pullback - Yahoo Finance
Hims & Hers Scales Technology-Driven Care as Profitability Evolves - Yahoo Finance
Healthcare Stocks To Keep An Eye OnDecember 15th - MarketBeat
Hims & Hers Health, Inc. $HIMS Holdings Raised by Nomura Holdings Inc. - MarketBeat
Castleark Management LLC Invests $2.92 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
Marex Group plc Invests $53.63 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health Inc. Stock (HIMS) Opinions on Q3 Earnings and Regulatory Challenges - Quiver Quantitative
Biomarker Testing Experiences - Trend Hunter
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know - sharewise.com
Hims & Hers Expands Weight-Management Program to the United Kingdom - Finviz
Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell? - MSN
Hims Hair Loss Solutions: Will the Convenient Option Work for You? - The National Council on Aging (NCOA)
Why Novo Nordisk Stock Topped the Market on Thursday - AOL.com
Hims & Hers targets UK’s weight loss market - eMarketer
Hims & Hers Expands Its Technology-Driven Personalized Virtual Care - The Globe and Mail
Hims & Hers Health's Options: A Look at What the Big Money is Thinking - Benzinga
Insider Sell Alert: Perez Garcia Andrea G Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus
Hims & Hers Health (NYSE:HIMS) Director Garcia Andrea Perez Sells 2,500 Shares of Stock - MarketBeat
Hims stock falls after lawmakers propose GLP-1 compounding restrictions By Investing.com - Investing.com Nigeria
Hims stock falls after lawmakers propose GLP-1 compounding restrictions - Investing.com
High Short-Interest Stocks to Buy Before Q1 2026 - Investing.com
Hims & Hers launches weight-loss business in UK - pharmaphorum
Is TEM Stock a Buy, Hold, or Sell During Its Pivotal Transition? - Finviz
Hims & Hers Health (NYSE:HIMS) Earns Overweight Rating from Analysts at Barclays - MarketBeat
Hims & Hers Expands Weight Loss Program to the U.K. - Yahoo Finance
Hims & Hers (HIMS) Expands Weight Loss Program to the UK - GuruFocus
HIMS Expands Weight Loss Program to the UK - GuruFocus
Hims & Hers brings weight loss program to the U.K. (HIMS:NYSE) - Seeking Alpha
Hims and Hers to offer weight-loss treatments in UK - The Mighty 790 KFGO
Hims & Hers Brings Comprehensive Weight Loss Programme to the UK - PA Media
Hims & Hers launches weight loss program in UK with Hers platform - StreetInsider
Does The Rally In Hims And Hers Health Still Leave Room For Growth In 2025 - Yahoo Finance
(HIMS) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
What Analysts Think Is Changing the Hims and Hers Story for Long Term Investors - Yahoo Finance
Hims & Hers Plunges 29.1% in 6 Months: Time to Hold the Stock or Sell? - Finviz
Barclays Initiates Coverage on Hims & Hers Health (HIMS) with Ov - GuruFocus
5 High Short-Interest Stocks to Buy Before Q1 2026 - MarketBeat
XTX Topco Ltd Cuts Stock Holdings in Hims & Hers Health, Inc. $HIMS - MarketBeat
Barclays Initiates Hims & Hers Health With Overweight Rating, $48 Price Target - marketscreener.com
Invesco Ltd. Purchases 2,128,587 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers' YourBio Health Acquisition: How They Are About To Revolutionize Blood Testing! - Smartkarma
Barclays Initiates Coverage of HIMS with Positive Outlook - GuruFocus
Andrew Dudum: 100 Most Influential People in Healthcare 2025 - Modern Healthcare
OMCL vs. HIMS: Which Stock Should Value Investors Buy Now? - Yahoo Finance
Pharma company eyes Canada as patents lapse on weight-loss drugs - Benefits and Pensions Monitor
Truist Securities reiterates Hold rating on Hims and Hers stock amid soft Q4 trends - Investing.com UK
Hims Hers Health Inc (HIMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.66%
1.82%
자본화:
|
볼륨(24시간):